A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

NCT02151110 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

NCT04674189 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

NCT04449276 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults

NCT02114268 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557

NCT00578682 ·Status: COMPLETED ·Phase: PHASE1

MEDI-557 Adult Dosing

NCT01562938 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of LY3832479 (LY-CoV016) in Healthy Participants

NCT04441931 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914

NCT01929629 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

NCT04652102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)

NCT04839146 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate MEDI-534 in Healthy Adults

NCT00111878 ·Status: COMPLETED

A Study of LY3832479 (LY-CoV016) in Healthy Participants 1

NCT04611789 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of MGD010 in Healthy Subjects

NCT02376036 ·Status: COMPLETED ·Phase: PHASE1

Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults

NCT02547792 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

NCT07205796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

NCT06057064 ·Status: COMPLETED ·Phase: PHASE2

First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects

NCT04893512 ·Status: COMPLETED ·Phase: PHASE1

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373472 ·Status: COMPLETED ·Phase: PHASE2

A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study

NCT05038618 ·Status: COMPLETED ·Phase: PHASE2

Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373485 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011

NCT06925919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)

NCT04679909 ·Status: COMPLETED ·Phase: PHASE1

A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

NCT00002059 ·Status: COMPLETED ·Phase: NA

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults

NCT03829384 ·Status: COMPLETED ·Phase: PHASE1